Association analysis of TGFBR3 gene with Vogt-Koyanagi-Harada disease and Behcet's disease in the Chinese Han population

Current Eye Research

Volumn 37, Issue 4, 2012, Pages 312-317

  Chen, Yuanyuan ^a   Yang, Peizeng ^a   Li, Fuzhen ^b   Hou, Shengping ^a   Jiang, Zhengxuan ^a   Shu, Qinmeng ^a   Kijlstra, Aize ^c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Association; Behcet's disease; Polymorphisms; TGFBR3; Vogt Koyanagi Harada (VKH) disease

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3;

ADULT; ARTICLE; BEHCET DISEASE; CHI SQUARE TEST; CHINESE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STRATIFICATION; TH17 CELL; VOGT KOYANAGI SYNDROME;

ADULT; BEHCET SYNDROME; CHINA; DNA; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 84859047542     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.635398     Document Type: Article

References (40)

1. Yang P, Zhang Z, Zhou H et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30:943-948. (Pubitemid 43154688)
2. Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007;114:606-614.
3. Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2006;46:111-122. (Pubitemid 44084839)
4. Forster DJ, Cano MR, Green RL, Rao NA. Echographic features of the Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol. 1990;108:1421-1426. (Pubitemid 20344697)
5. Keino H, Okada AA. Behçet's disease: Global epidemiology of an old silk road disease. Br J Ophthalmol. 2007;91:1573-1574. (Pubitemid 350207369)
6. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999;341:1284-1291.
7. Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A. Clinical features of chinese patients with Behçet's disease. Ophthalmology. 2008;115:312-318.
8. Fresko I, Soy M, Hamuryudan V et al. Genetic anticipation in Behçet's syndrome. Ann Rheum Dis. 1998;57:45-48.
9. Ohno S. Immunological aspects of Behçet's and Vogt- Koyanagi-Harada's diseases. Trans Ophthalmol Soc UK. 1981;101:335-341. (Pubitemid 12126279)
10. Mizuki N, Ota M, Yabuki K, Katsuyama Y, Ando H, Palimeris GD et al. Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000;41:3702-3708.
11. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt- Koyanagi-Harada disease. J Immunol. 2000;165:7323-7329. (Pubitemid 32001213)
12. Dilek K, Ozçimen AA, Saricaoglu H et al. Cytokine gene polymorphisms in Behçet's disease and their association with clinical and laboratory findings. Clin Exp Rheumatol. 2009;27:73-78.
13. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T et al. Genome-wide association studies identify IL23RIL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat gene. 2010;42:703-706.
14. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat genet. 2010;42:698-702.
15. Chi W, Yang P, Li B et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007;119:1218-1224. (Pubitemid 46667160)
16. Chi W, Zhu X, Yang P et al. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci. 2008;49:3058-3064.
17. O'Garra A, Stockinger B, Veldhoen M. Differentiation of human T(H)-17 cells does require TGF-β! Nat Immunol. 2008;9:588-590. (Pubitemid 351712629)
18. Mangan PR, Harrington LE, O'Quinn DB et al. Transforming growth factor-β induces development of the T(H)17 lineage. Nature. 2006;441:231-234.
19. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORgammat. Nat Immunol. 2008;9:641-649. (Pubitemid 351714729)
20. Kang JS, Liu C, Derynck R. New regulatory mechanisms of TGF-β receptor function. Trends Cell Biol. 2009;19:385-394.
21. Massagué J, Blain SW, Lo RS. TGFβ signaling in growth control, cancer, and heritable disorders. Cell. 2000;103:295-309.
22. You HJ, How T, Blobe GC. The type III transforming growth factor-β receptor negatively regulates nuclear factor . B signaling through its interaction with β-arrestin2. Carcinogenesis. 2009;30:1281-1287.
23. Blobe GC, Schiemann WP, Pepin MC et al. Functional roles for the cytoplasmic domain of the type III transforming growth factor β receptor in regulating transforming growth factor β signaling. J Biol Chem. 2001;276:24627-24637.
24. Xiong DH, Liu XG, Guo YF, Tan LJ, Wang L, Sha BY et al. Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet. 2009;84: 388-398.
25. Kim HK, Jang TW, Jung MH et al. Association between genetic variations of the transforming growth factor βreceptor type III and asthma in a Korean population. Exp Mol Med. 2010;42:420-427.
26. Read RW, Holland GN, Rao NA et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647-652. (Pubitemid 32422124)
27. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's disease. Lancet. 1990;335:1078-1080.
28. Japan BsDRco. The Revised Criteria and Manual of Treatments of Behcet's disease. Tokyo: Ministry of Health and Welfare. 2003:11-29." is corrected as "Behcet's Disease Research Committee of Japan: The Revised Criteria and Manual of Treatments of Behcet's Disease. Ministry of Health and Welfare 2003. Tokyo, Japan; 11, 2003.
29. Shindo Y, Ohno S, Nakamura S, Onoé K, Inoko H. A significant association of HLA-DPB1. *0501 with Vogt-Koyanagi-Harada' disease results from a linkage disequilibrium with the primarily associated allele, DRB1.*0405. Tissue Antigens. 1996;47:344-345.
30. Zhao M, Jiang Y, Abrahams IW. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Arch Ophthalmol. 1991;109:368-370.
31. Mizuki N, Ota M, Katsuyama Y et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. Arthritis Rheum. 1999;42:1961-1966. (Pubitemid 30257763)
32. Mizuki N, Inoko H, Ando H et al. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B.*5101. Am J Ophthalmol. 1993;116:406-409. (Pubitemid 23299483)
33. Mizuki N, Yabuki K, Ota M et al. Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behçet's disease. Tissue Antigens. 2002;60: 396-399. (Pubitemid 36020796)
34. Mizuki N, Ota M, Katsuyama Y et al. Sequencing-based typing of HLA-B. *51 alleles and the significant association of HLA-B. *5101 and -B. *5108 with Behçet's disease in Greek patients. Tissue Antigens. 2002;59:118-121. (Pubitemid 34620552)
35. Horie Y, Kitaichi N, Takemoto Y et al. Polymorphism of IFN-γ gene and Vogt-Koyanagi-Harada disease. Mol Vis. 2007;13:2334-2338.
36. Jiang Z, Yang P, Hou S, Li F, Zhou H. Polymorphisms of IL23R and Vogt-Koyanagi-Harada syndrome in a Chinese Han population. Hum Immunol. 2010;71:414-417.
37. Du L, Yang P, Hou S et al. Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome. Clin Immunol. 2008;127:43-48.
38. Hou S, Yang P, Du L et al. Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population. Mol Vis. 2008;14:2597-2603.
39. Hou S, Yang P, Du L et al. SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease. Clin Immunol. 2008;129:170-175.
40. Li K, Yang P, Zhao M et al. Polymorphisms of FCRL3 in Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome. Mol Vis. 2009;15:955-961.